• -
  • English
  • Japanese
  • Korean
表紙
市場調查報告書
商品編碼
1064706

Rituxan(Rituximab)製劑的全球市場:2021年∼2027年

Rituxan Rituximab Drug Market 2021-2027
出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 95 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球Rituxan(Rituximab)製劑的市場規模，在預測期間內預計以大幅度的年複合成長率擴大。類風濕性關節炎，與慢性淋巴性白血病等的慢性疾病的盛行率的上升，製藥公司對開發新藥的高額投資，成為該市場成長的主要原因。還有主要加入企業的M&A，新產品銷售，事業擴大等策略的採用高漲，市場在預測期間內預計擴大。

本報告提供全球Rituxan(Rituximab)製劑市場相關調查，市場概要各用途，各流通管道，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場區隔

  • 全球Rituxan(Rituximab)製劑市場，各用途
    • 靜脈內使用
    • 皮下使用
  • 全球Rituxan(Rituximab)製劑市場，各流通管道
    • 院內藥局
    • 零售藥局
    • 線上藥局
    • 其他

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • Biogen Idec
  • F. Hoffmann-La Roche AG.
  • The Chugai Pharmaceutical Co., Ltd.
  • Zenyaku Kogyo Co. Ltd.
目錄
Product Code: OMR2024192

Global Rituxan (rituximab) Drug Market Size, Share & Trends Analysis Report, by Application (Intravenous Use and Subcutaneous Use), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) Forecast (2021-2027)

The global rituxan (rituximab) drug market is anticipated to grow at a considerable CAGR during the forecast period. The rising prevalence of chronic disorders such as rheumatoid arthritis, chronic lymphocytic leukemia, and others and significant investment by the pharmaceutical companies in new drug development are the major factors for the market growth. In addition, rising adoption of strategies such as mergers and acquisition, new product launch, business expansion by key players, the market is expected to rise over the projected period. For instance, in September 2021, Zenyaku Kogyo Co., Ltd. And Chugai Pharmaceutical Co., Ltd. announced that that Zenyaku obtained approval from the Ministry of Health, Labor and Welfare (MHLW), for an anti-CD20 monoclonal antibody, Rituxan® injection 100 mg and 500 mgfor an additional indication of systemic sclerosis (SSc).

The global rituxan (rituximab) drug market is segmented based on application and distribution channel. On the basis of application, the market is sub-segmented into intravenous use and subcutaneous use. Based on distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others.

Geographically, the global rituxan (rituximab) drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global rituxan (rituximab) drug market include Zenyaku Kogyo Co. Ltd., Biogen Idec, The Chugai Pharmaceutical Co., Ltd., F. Hoffmann-La Roche AG., and others.

Market Segmentation

1. Global Rituxan (rituximab) Drug Market Research and Analysis by Application

2. Global Rituxan (rituximab) Drug Market Research and Analysis by Distribution Channel

The Report Covers

  • Comprehensive research methodology of the global rituxan (rituximab) Drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global rituxan (rituximab) Drug market.
  • Insights about market determinants that are stimulating the global rituxan (rituximab) Drug market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Rituxan (rituximab) Drug Market by Application
    • 4.1.1. Intravenous Use
    • 4.1.2. Subcutaneous Use
  • 4.2. Global Rituxan (rituximab) Drug Market by Distribution Channel
    • 4.2.1. Hospital Pharmacy
    • 4.2.2. Retail Pharmacy
    • 4.2.3. Online Pharmacy
    • 4.2.4. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Biogen Idec
  • 6.2. F. Hoffmann-La Roche AG.
  • 6.3. The Chugai Pharmaceutical Co., Ltd.
  • 6.4. Zenyaku Kogyo Co. Ltd.

LIST OF TABLES

  • 1. GLOBAL RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 2. GLOBAL RITUXAN (RITUXIMAB) DRUG FOR INTRAVENOUS USE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL RITUXAN (RITUXIMAB) DRUG FOR SUBCUTANEOUS USEMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 5. GLOBAL RITUXAN (RITUXIMAB) DRUG IN Hospital PharmacyMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL RITUXAN (RITUXIMAB) DRUG IN Retail PharmacyMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL RITUXAN (RITUXIMAB) DRUG IN Online PharmacyMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL RITUXAN (RITUXIMAB) DRUG BY OTHER DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. NORTH AMERICAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 10. NORTH AMERICAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 12. EUROPEAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 13. EUROPEAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 14. EUROPEAN RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 15. ASIA-PACIFIC RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 16. ASIA-PACIFIC RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY CONNECTIVITY, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. REST OF THE WORLD RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD RITUXAN (RITUXIMAB) DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL RITUXAN (RITUXIMAB) DRUG MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 2. GLOBAL RITUXAN (RITUXIMAB) DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
  • 3. GLOBAL RITUXAN (RITUXIMAB) DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD RITUXAN (RITUXIMAB) DRUG MARKET SIZE, 2020-2027 ($ MILLION)